About 1 000 reports

  • 2.8.3 TARGETED THERAPIES
  • summarizes the treatment algorithm for patients diagnosed

Resistance to one targeted therapy does not therefore necessarily cause resistance to other products.

  • Chemotherapy
  • Targeted Therapy
  • Therapy
  • Market Size
  • Merck & Co., Inc.
  • Launch of Targeted Therapies and Immuno-Oncology Agents to Address Unmet Need in TNBC and Further Drive Market Growth
  • 6.5.2 ANNUAL COST OF THERAPY

Subjects were randomized in a ##:##:## ratio to Weakest performers Strongest performers cycles). receive no additional treatment, one year of Herceptin treatment or two years of Herceptin treatment.

  • Cancer
  • Targeted Therapy
  • AstraZeneca PLC
  • Novartis AG
  • Roche Group
  • THOMSON NC, ET AL. (2012). LEBRIKIZUMAB IN THE PERSONALIZED MANAGEMENT OF ASTHMA. BIOLOGICS: TARGETS AND THERAPY; 6: 329-335

IN IPF TREATMENT, THE MOST COMMON TARGET IS AN ENZYME TARGET.

  • Targeted Therapy
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Biologics, Inc.
  • Diagnosed prevalence and treated pool for targeted therapies to increase over the forecast period
  • 7.1.2 INCREASING AWARENESS AND DIAGNOSIS

Subjects were randomized in a ##:##:## ratio to receive no additional treatment, one year of Herceptin treatment or two years of Herceptin treatment.

  • Targeted Therapy
  • Market Size
  • AstraZeneca PLC
  • Genentech, Inc.
  • Novartis AG

Targeted Therapies in Asthma: KOL Insight [2018] ##.

  • Asthma
  • Targeted Therapy
  • North America
  • United Kingdom
  • United States
  • NEW THERAPIES INCREASE MARKET SEGMENTATION AND DIVERSIFY TREATMENT
  • 6.3.2 ANNUAL COST OF THERAPY

One such limitation is the lack of diversity in targeted therapies.

  • Targeted Therapy
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novartis AG
  • Roche Group

Targeted Therapies in Asthma: KOL Insight: Update Bulletin [April 2017] This edition presents key opinion leader (KOL) views on recent developments in the targeted asthma treatment market Topics covered include; GlaxoSmithKline’s (GSK) presentation of new data at

  • Monoclonal Antibody
  • Salicylic Acid
  • Targeted Therapy
  • Therapy
  • World
  • 3.2 HER2-Targeted Therapy
  • 6.7 Japan

Avelumab, a targeted therapy for PD-## receptor, and trastuzumab are the best products in terms of PFS.

  • Monoclonal Antibody
  • Targeted Therapy
  • Market Size
  • AstraZeneca PLC
  • Roche Group
  • BCMA TARGETED THERAPIES: DEVELOPMENT PIPELINE,
  • BCMA TARGETED THERAPIES: DISTRIBUTION BY INDICATION

PATIENTS RECEIVED THE THERAPY AS SPLIT DOSE INFUSIONS OF ##-##X## OR ##-##X## CELLS OVER THREE DAYS (##% ON DAY ##, ##% ON DAY ##, AND ##% ON DAY ##).

  • Targeted Therapy
  • United States
  • Affimed Therapeutics AG
  • Amgen Inc.
  • Celgene Corporation
  • 2.6.4 TARGETED THERAPIES
  • Non-hematological Cancer, Global, Key Marketed Products and Approved Indications, 2015

Targeted therapies for breast cancer.

  • Targeted Therapy
  • Market Size
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Pfizer Inc.

Targeted Therapies in Asthma - 2017 ##.

  • Medical Biotechnology
  • Respiratory Treatment
  • Targeted Therapy
  • Therapy
  • United States
  • 2.7.3.2 Targeted Therapy
  • 7.2.2 DEALS BY STAGE OF DEVELOPMENT AND VALUE

Targeted therapies, cancer immunotherapies and therapies targeting signal transduction therapies feature prominently, reflecting the success of such therapies in the current market.

  • Targeted Therapy
  • Market Size
  • Celgene Corporation
  • Novartis AG
  • Roche Group
  • Targeted Therapy Drug Import
  • Targeted Therapy Drug

Targeted Therapy Drug Import The total Targeted Therapy Drug imports volume in China reached ##. ## million yuan in 2017.

  • Targeted Therapy
  • China
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

Targeted Therapies In Asthma: Update Bulletin [April 2016] This edition presents key opinion leader (KOL) views on recent developments in the asthma market, including the clinical role of Nucala (mepolizumab; GSK) the prospects for Teva’s recently approved Cinqair (reslizumab) and

  • Medical Biotechnology
  • Monoclonal Antibody
  • Oncology
  • Targeted Therapy
  • Therapy
  • 8.3 RESISTANCE TO HER2-TARGETED THERAPIES
  • IXEMPRA SWOT ANALYSIS, 2017

Pfizer' s current portfolio for breast cancer consists of one marketed hormone therapy, Aromasin, and one targeted therapy, Ibrance, which is being investigated in Phase III for HER##-positive disease.

  • Targeted Therapy
  • Company
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • Targeted Therapy Drug Sales Volume (million Yuan)
  • Targeted Therapy Drug Sales Volume by Drugs Classification in 2017(percent)

The next stage of targeted therapies will focus on finding which patients will respond to which targeted therapies.

  • Targeted Therapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • MOST PRESCRIBED TARGETED THERAPIES FOR MCRC, BY SEGMENT IN THE 8MM, 2016
  • STIVARGA SWOT ANALYSIS, 2016

MOLECULAR THERAPY; ##(##): ##-##.

  • Targeted Therapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • Treatment Response and Failure in CML Patients
  • I. Global CML Market

Targeted Therapy Targeted therapy targets the onco-genes, proteins, or the tissue environment that contributes to cancer development and survival.

  • Targeted Therapy
  • Incyte Corporation
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

In addition, factors such as rising focus on the development of targeted therapies and advancements in antigen specific T-cell therapy for cancer are providing traction for global Tumor-specific market growth over the forecast period (2018- 2023).

  • Medical Biotechnology
  • Monoclonal Antibody
  • Targeted Therapy
  • World
  • Forecast
  • TARGETED THERAPY
  • Market drivers

Source: Technavio TARGETED THERAPY Targeted therapy focuses on specific abnormalities within cancer cells that enable to survive.

  • Targeted Therapy
  • Amgen Inc.
  • Celgene Corporation
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Launch of Novel Targeted Therapies and Biosimilars to Drive Market Growth
  • B) Aggregate deal value by molecule type

Psoriasis: Targets and Therapy; ##: ##-##.

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Novartis AG
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Targeted Therapy Drug Major Producer and Their

The targeted therapy drug has strong specificity and better curative effort.

  • Targeted Therapy
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd
  • Wyeth China Inc.
  • 2.8.3 TARGETED THERAPIES
  • 3.3 Epidermal Growth Factor Receptor Targeted Therapies

Oncobiology and Targets; ##(##): ## Mirghani H, et al. (2015).

  • Targeted Therapy
  • Market Size
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Entry of Novel Targeted Therapies and Triple-Combination Therapies to Expand Treatment Options
  • Pipeline Analysis

The pipeline is strong, with targeted therapies expected to be launched during the forecast period, including IL-##-targeting therapies, which are expected to witness high uptake.

  • Targeted Therapy
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • OPPORTUNITY REMAINS FOR THE DEVELOPMENT OF NOVEL TARGETED THERAPIES
  • DEVELOPMENT STRATEGIES FOCUS ON IMPROVING TARGETED THERAPY OPTIONS

IN THE TARGETED THERAPY ARENA, ALL CLASSES OF TARGETED THERAPIES WILL EXPERIENCE POSITIVE GROWTH.

  • Targeted Therapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Targeted therapy-IR
  • Targeted therapy-IR

US-based KOL Europe-based KOL Europe-based KOL Current use of tocilizumab in RA (##/ ##) Targeted therapy-IR Patients in which tocilizumab is currently used KOL Insight: Most KOLs position tocilizumab after anti-TNFs, partly due to payer pressure, with first-line use pos

  • Medical Biotechnology
  • Monoclonal Antibody
  • Targeted Therapy
  • European Union
  • United States
  • 4 MAJOR MAB-TARGETING THERAPY AREAS
  • 2.1 INITIAL MAB DEVELOPMENT

Targeted therapies were required because systemic, non-targeted treatments were often toxic and resulted in severe off-target effects.

  • Targeted Therapy
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Genentech, Inc.
  • Johnson & Johnson
  • TARGETED THERAPIES
  • CDK Inhibitors

TREATMENT DAYS: GAZYVA IS ADMINISTERED AT A DOSE OF ##, ##MG IV ON DAYS ##/ ##, ##, AND ## OF CYCLE ##, AND ON DAY ## OF CYCLES ##-##.

  • Targeted Therapy
  • AbbVie Inc.
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Roche Group
  • 9.6.2 MOLECULAR TARGETED THERAPIES
  • BRAF, MEK AND C-KIT TARGETED THERAPIES

S PD-## TARGETING KEYTRUDA, BMS' S PD-## TARGETING OPDIVO AND, AMGEN' S ONCOLYTIC VIRAL THERAPY IMLYGIC.

  • Targeted Therapy
  • Australia
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group
  • 8.2 MORE EFFICACIOUS FIRST-LINE THERAPIES
  • 10.3.4 BAYER

ONE SUCH NOVEL TARGET IS INTEGRIN PEPTIDES.

  • Targeted Therapy
  • Allergan plc
  • Clearside Biomedical, Inc.
  • Novartis AG
  • Regeneron Pharmaceuticals, Inc.